CRISPR Clinics

and the Casualization of Gene Editing

The infusion center hums like a showroom for organs you can’t afford. Dr. Kelvin watches the efficiency and remembers when he thought DNA was read-only. Now it’s read-write, with a price tag that would make a hedge fund manager wince. Eleven years ago, he held a molecular scalpel that could rewrite the code of life. Today, that tool powers Casgevy, the …